Cancer biotech files for $35M IPO; Nordic Nanovector raises cash;

@FierceBiotech: Navitor grabs a $23.5M A round to tackle a key crossroad for disease. More | Follow @FierceBiotech

@JohnCFierce: Man, that Burrill lawsuit makes for interesting reading. Story | Follow @JohnCFierce

@DamianFierce: J&J Innovation's summer class of biotechs targets obesity, insomnia, heart failure, cancer and more. News | Follow @DamianFierce

> The Israeli cancer biotech Silenseed has filed plans to raise $35 million in an IPO on Nasdaq. Story

> Norway's Nordic Nanovector says it has raised NOK 250 million in a pre-IPO raise. Release

> The cancer diagnostics company Signal Genetics has raised $9 million through the sale of shares. Story

Medical Device News

@FierceMedDev: EnteroMedics up in early trading after mixed FDA panel vote. More | Follow @FierceMedDev

@StacyALawrence: Medtronic merger could give Covidien execs an $80M payout. Story | Follow @StacyALawrence

@MichaelGFierce: UPenn team combats Parkinson's with immunotherapy that targets neuron killers. Story from FierceBiotechResearch | Follow @MichaelGFierce

@EmilyWFierce: Single gene mutations that lower triglyceride levels could spur the development of a new class of heart disease drugs. Article | Follow @EmilyWFierce

> Data: Medtronic personalized defibrillator safer, cheaper. More

> Covidien endovascular unit could be target for cuts after Medtronic merger. Story

> Covidien recalls potentially faulty Hydrofinity guidewire. Article

Pharma News

@FiercePharma: Now out: This week's issue of FierceVaccinesWeekly report | Follow @FiercePharma

@TracyStaton: Trending now at FiercePharma: Novo Nordisk lays out plans to recruit 6,000 workers in R&D, production. Story | Follow @TracyStaton

@EricPFierce: How much are the big dogs of Big Pharma paid? A lot. See the top 15 highest paid CEOs here. | Follow @EricPFierce

@CarlyHFierce: Czech scientists have a Lyme disease vaccine ready for animal use. A few of my favorite things in here, and Lyme disease isn't one of them. Story | Follow @CarlyHFierce

> J&J Innovation spotlights its slate of new biotech deals. Item

> Want a Big Pharma job? Apply in an emerging market--or think smaller. More

> Study: Suicides rise in wake of 'black box' warnings on antidepressants. Article

Vaccines News

> Merck, Sanofi JV wins anal cancer indication for Gardasil in EU. Story

> Themis Chikungunya prophylactic hits Phase I goal. More

> Pfizer puts the heat on Novartis with FDA MenB filing. Article

> Novartis submits Bexsero to FDA in race for MenB market. News

> MenB survivors call for Bexsero coverage in Australia. Item

> Novartis facility grabs FDA license to produce cell-culture vaccines. Report

Pharma Manufacturing News

> EMA GMP inspectors working group making updates for this year. Item

> Ranbaxy's FDA problems stymie launch of generic Nexium and the relief it would bring to consumers. More

> Dr. Reddy's initiates 2 recalls even as it invests to remove human error. Story

> Grifols doubles capacity with new U.S. plasma fractionation plant. Article

> Counterfeit antibiotics feed drug resistance, superbugs. News

> FDA finds fault with Chinese API maker. Report